Article references February 2022 issue 169


  1. Shimizu et al (2019). Life-long consumption of lemon polyphenols can delay age-related changes seen in gut including changes in the balance of beneficial gut bacteria. Sci Rep. 9: 3671
  2. Kondo et al (2009). Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects. Biosci Biotechnol Biochem. 73(8): 1837-43. doi: 10.1271/bbb.90231
  3. Ostman et al (2005). Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects. Eur J Clin Nutr. 59(9): 983-8. doi: 10.1038/sj.ejcn.1602197
  4. Grgic et al (2020). Wake up and smell the coffee: caffeine supplementation and exercise performance-an umbrella review of 21 published meta-analyses. Br J Sports Med. 54(11): 681-688. doi: 10.1136/bjsports-2018-100278



  1. The Food People (2021). Food and Beverage Trends 2022-2023.


  1. International Diabetes Federation diabetes atlas, ninth edition (2019).
  2. Diabetes UK. What is gestational diabetes?
  3. World Health Organisation. WHO Diagnostic Criteria and Classification of Hyperglycaemia first Detected in Pregnancy. Report WHO/NMH/MND/13.2. Geneva, Switzerland: WHO, 2014
  4. National Institute for Health and Care Excellence (NICE). Diabetes in pregnancy: management from preconception to the postnatal period NICE guideline [NG3].
  5. Nature Reviews (2019). Gestational diabetes mellitus. Nat Rev Dis Primers 5, 48.
  6. Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational Diabetes Mellitus: Mechanisms, Treatment and Complications. Trends Endocrinol Metab. 2018 Nov; 29(11): 743-754. doi: 10.1016/j.tem.2018.09.004. Epub 2018, Oct 5. PMID: 302973
  7. Sweeting AN, Wong J, Appelblom H, Ross GP, Kouru H, Williams PF. A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus. Fetal Diagn Ther 2019; 45: 76-84
  8. Sonagra AD, Biradar SMKD, Murthy DSJ. Normal pregnancy – a state of insulin resistance. J Clin Diagn Res. 2014; 8(11): CC01-CC3. doi:10.7860/JCDR/2014/10068.5081
  9. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018; 19(11): 3342. Published 2018 Oct 26. doi:10.3390/ijms19113342
  10. Šimják P, Anderlová K, Cinkajzlová A, Pařízek A, Kršek M, Haluzík M. The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus. Minerva Endocrinol. 2020 Sep; 45(3): 228-242. doi: 10.23736/S0391-1977.20.03192-2. PMID: 33000620
  11. Baz B, Riveline JP, Gautier JF. Endocrinology of pregnancy: Gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016 Feb; 174(2): R43-51. doi: 10.1530/EJE-15-0378. Epub 2015 Oct 1. PMID: 26431552
  12. Dahlgren J. Pregnancy and insulin resistance. Metab Syndr Relat Disord. 2006 Summer; 4(2): 149-52. doi: 10.1089/met.2006.4.149. PMID: 18370761
  13. Pérez-Pérez A, Vilariño-García T, Guadix P, Dueñas JL, Sánchez-Margalet V. Leptin and Nutrition in Gestational Diabetes. Nutrients. 2020; 12(7): 1970. Published 2020 Jul 2. doi:10.3390/nu12071970
  14. Murray SR, Reynolds RM. Short- and long-term outcomes of gestational diabetes and its treatment on fetal development. Prenat Diagn. 2020 Aug; 40(9): 1085-1091. doi: 10.1002/pd.5768. Epub 2020 Jul 1. PMID: 32946125
  15. Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015; 66 Suppl 2: 14-20. doi: 10.1159/000371628. Epub 2015 Jun 2. PMID: 26045324
  16. Kole MB, Ayala NK, Clark MA, Has P, Esposito M, Werner EF. Factors Associated with Hypoglycaemia among Neonates Born to Mothers with Gestational Diabetes Mellitus. Diabetes Care. 2020 Dec; 43(12): e194-e195. doi: 10.2337/dc20-1261. Epub 2020 Oct 13. PMID: 33051333
  17. Pintaudi B, Fresa R, Dalfrà M, Dodesini AR, Vitacolonna E, Tumminia A, Sciacca L, Lencioni C, Marcone T, Lucisano G, Nicolucci A, Bonomo M, Napoli A; STRONG Study Collaborators. The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study. Acta Diabetol. 2018 Dec; 55(12): 1261-1273. doi: 10.1007/s00592-018-1208-x. Epub 2018 Sep 17. PMID: 30221320
  18. Chandler‐Laney PC, Bush NC, Granger WM, Rouse DJ, Mancuso MS, Gower BA. Overweight status and intrauterine exposure to gestational diabetes are associated with children's metabolic health. Pediatr Obes. 2012; 7(1): 44-52
  19. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess (Full Rep). 2012 Oct; (210): 1-327. PMID: 24423035; PMCID: PMC4781607
  20. Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin Obstet Gynaecol. 2011 Feb; 25(1): 37-49. doi: 10.1016/j.bpobgyn.2010.10.004. Epub 2010 Nov 5. PMID: 21115402
  21. Nwali SA, Onoh RC, Dimejesi IB et al. Universal versus selective screening for gestational diabetes mellitus among antenatal clinic attendees in Abakaliki: using the one-step 75gram oral glucose tolerance test. BMC Pregnancy Childbirth 21, 735 (2021).
  22. Hillier TA, Vesco KK, Whitlock EP, Pettitt DJ, Pedula KL, Beil TL. Screening for Gestational Diabetes Mellitus [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 May. Report No: 08-05115-EF-1. PMID: 20722157
  23. Brown J, Martis R, Hughes B, Rowan J, Crowther CA. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017 Jan 25; 1(1): CD011967. doi: 10.1002/14651858.CD011967.pub2. PMID: 28120427; PMCID: PMC6464763
  24. Bao LX, Shi WT, Han YX. Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2021 Aug; 34(16): 2741-2753. doi: 10.1080/14767058.2019.1670804. Epub 2019 Sep 26. PMID: 31558075
  25. Zhang M, Zhou Y, Zhong J, Wang K, Ding Y, Li L. Current guidelines on the management of gestational diabetes mellitus: a content analysis and appraisal. BMC Pregnancy Childbirth. 2019; 19(1): 200. Published 2019 Jun 13. doi:10.1186/s12884-019-2343-2
  26. Tobias DK, Zhang C, Chavarro J et al. Pre-pregnancy adherence to dietary patterns and lower risk of gestational diabetes mellitus. Am J Clin Nutr. 2012; 96(2): 289-295. doi:10.3945/ajcn.111.028266
  27. Song C, Li J, Leng J, Ma RC, and Yang X (2016). Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomised controlled trial. Obesity Reviews, vol 17, no 10, p 960-969
  28. Han S, Middleton P, Shepherd E, Van Ryswyk E, Crowther CA. Different types of dietary advice for women with gestational diabetes mellitus. Cochrane Database Syst Rev. 2017 Feb 25; 2(2): CD009275. doi: 10.1002/14651858.CD009275.pub3. PMID: 28236296; PMCID: PMC6464700
  29. Filardi T, Panimolle F, Crescioli C, Lenzi A, Morano S. Gestational Diabetes Mellitus: The Impact of Carbohydrate Quality in Diet. Nutrients. 2019 Jul 9; 11(7): 1549. doi: 10.3390/nu11071549. PMID: 31323991; PMCID: PMC6683084
  30. Mierzyński R, Poniedziałek-Czajkowska E, Sotowski M, Szydełko-Gorzkowicz M. Nutrition as Prevention Factor of Gestational Diabetes Mellitus: A Narrative Review. Nutrients. 2021; 13(11): 3787. Published 2021 Oct 26. doi:10.3390/nu13113787
  31. Gilbert L, Gross J, Lanzi S et al. How diet, physical activity and psychosocial wellbeing interact in women with gestational diabetes mellitus: an integrative review. BMC Pregnancy Childbirth 19, 60 (2019).
  32. Martis R et al (2018). Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 8, CD012327
  33. Nicklas J, Miller L, Zera C, Davis R, Levkoff S, Seely E. Factors Associated with Depressive Symptoms in the Early Postpartum Period among Women with Recent Gestational Diabetes Mellitus. Matern Child Health J. 2013; 17(9): 1665-72
  34. Horsch A, Gilbert L, Lanzi S, Gross J, Kayser B, Vial Y, Simeoni U, Hans D, Berney A, Scholz U. Improving cardiometabolic and mental health in women with gestational diabetes mellitus and their offspring: study protocol for MySweetHeart Trial, a randomised controlled trial. BMJ Open. 2018; 8(2): e020462



  1. National Diet and Nutrition Survey Rolling Programme Years 9 to 11 (2016/2017 to 2018/2019). Available at:
  2. Hayhoe R et al (2021). Cross-sectional associations of schoolchildren’s fruit and vegetable consumption and meal choices, with their mental wellbeing: a cross-sectional study.
  3. You Gov 2019 survey on behalf of Veg Power. Data on file
  4. You Gov 2021 survey on behalf of Veg Power. Data on file
  5. Schools survey conducted by ‘The Smaller Boat’ on behalf of Veg Power. Data on file
  6. Families survey conducted by ‘The Smaller Boat’ on behalf of Veg Power. Data on file
  7. National Food Strategy - an independent review for Government. Available at:
  8. Data compiled by Pearl Metrics (an independent analytics consultancy) on behalf of Veg Power. Data on file



  1. Johnstone A (2015). Fasting for weight loss: an effective strategy or latest dieting trend? Int J Obes 39, 727-733
  2. BBC Horizon: Eat, Fast and Live Longer. Screened on BBC Two on 6 August 2012
  3. Mosley M, Spencer M (2013). The fast diet. London: Short Books;
  4. Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B, Cutler RG, Evans G, Whiteside S, Maudsley S, Camandola S, Wang R, Carlson OD, Egan JM, Mattson MP, Howell A. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013 Oct;110(8): 1534-47
  5. Prevent Breast Cancer. 2-Day-Diet-FAQs.pdf - Prevent Breast Cancer Available here: [accessed 02.12.21]
  6. Sundfør TM, Svendsen M, Tonstad S. Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomised 1-year trial. Nutr Metab Cardiovasc Dis. 2018 Jul; 28(7): 698-706
  7. Conley M, Le Fevre L, Haywood C, Proietto J. Is two days of intermittent energy restriction per week a feasible weight loss approach in obese males? A randomised pilot study. Nutr Diet. 2018 Feb; 75(1): 65-72
  8. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A, Howell A. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomised trial in young overweight women. Int J Obes (Lond). 2011 May; 35(5): 714-27
  9. Headland ML, Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restriction on weight loss and weight maintenance after 12 months in healthy overweight or obese adults. Int J Obes (Lond). 2019 Oct; 43(10): 2028-2036
  10. Headland ML, Clifton PM and Keogh JB. Impact of intermittent vs continuous energy restriction on weight and cardiometabolic factors: a 12-month follow-up. Int J Obes 44, 1236-1242 (2020)
  11. Carter S, Clifton PM, Keogh JB. Effect of Intermittent Compared with Continuous Energy-Restricted Diet on Glycaemic Control in Patients with Type 2 Diabetes: A Randomised Noninferiority Trial. JAMA Netw Open. 2018 Jul 6; 1(3): e180756
  12. Harvey J, Howell A, Morris J, Harvie M. Intermittent energy restriction for weight loss: Spontaneous reduction of energy intake on unrestricted days. Food Sci Nutr. 2018 Feb 21; 6(3): 674-680
  13. Trepanowski JF, Kroeger CM, Barnosky A, Klempel MC, Bhutani S, Hoddy KK, Gabel K, Freels S, Rigdon J, Rood J, Ravussin E, Varady KA. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection among Metabolically Healthy Obese Adults: A Randomised Clinical Trial. JAMA Intern Med. 2017 Jul 1; 177(7): 930-938
  14. Cui Y, Cai T, Zhou Z, Mu Y, Lu Y, Gao Z, Wu J and Zhang Y (2020). Health Effects of Alternate-Day Fasting in Adults: A Systematic Review and Meta-Analysis. Front. Nutr
  15. De Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Ageing, and Disease. N Engl J Med. 2019 Dec 26; 381(26): 2541-2551. doi: 10.1056/NEJMra1905136. Erratum in: N Engl J Med. 2020 Jan 16; 382(3): 298. Erratum in: N Engl J Med. 2020 Mar 5; 382(10): 978
  16. Hajek P, Przulj D, Pesola F, McRobbie H, Peerbux S, Phillips-Waller A et al (2021). A randomised controlled trial of the 5:2 diet. PLoS ONE 16(11): e0258853. Available at: journal.pone



  1. Dalk HF et al (2017). Eating Habits and Associated Factors Among Adolescent Students in Jordan. Clin Nurs Res. 26(4): 538-552. doi: 10.1177/1054773816646308
  2. National Diet and Nutrition Survey Years 1 to 9 of the Rolling Programme (2008/2009 – 2016/2017): Time trend and income analyses. Available at:
  3. Public Health England (2016). Government Dietary Recommendations. Online. Available at:
  4. Solmi F et al (2021). Changes in the Prevalence and Correlates of Weight-Control Behaviours and Weight Perception in Adolescents in the UK, 1986-2015. JAMA Pediatr. 175(3): 267-275. doi: 10.1001/jamapediatrics.2020.4746
  5. Statistics and research on eating disorders. Online. Available at:
  6. The Vegan Society. Find out how many vegans there are in Great Britain. Online. Available at:



  1. Bapen, the European Nutrition for Health Alliance and the International Longevity Centre (2019). Malnutrition among Older People in the Community [online]. Available from:
  2. British Geriatrics Society (2019). Malnutrition: A significant threat to our health as we age [online]. Nutrition [viewed 29 November 2021]. Available from:
  3. NHS (2021). Huntington’s disease [online] [viewed 29 November 2021]. Available from:
  4. Brotherton A, Campos L, Rowell A, Zois V, Simpson AS and Rae D (2012). Special Report. Nutritional Management of Individuals with Huntington’s disease: nutritional guidance. Future Medicine part of Future Science Group (FSG) [online]. 2(1), p 33-43 [viewed 29 November 2021]. Available from:,on%20sound%20evidence%20and%20current%20best%20clinical%20practice
  5. Winchester Hospital (2021). Health Library. Nutritional Care for People with Huntington’s Disease [online] [viewed 29 November 2021]. Available from:
  6. Parkinson’s UK (2021). Information and Support. What is Parkinson’s? [online] [viewed 29 November 2021]. Available from:
  7. British Dietetic Association (2021). Best practice guidance for dietitians on the nutritional management of Parkinson’s [online]. National Hospital for Neurology & Neurosurgery [viewed 29 November 2021]. Available from:
  8. Dementia UK (2021). What is dementia? [online] [viewed 26 November 2021]. Available from:
  9. National Institute for Health and Care Excellence (2021). Dementia: How common is it? [online] [viewed 26 November 2021]. Available from;,65%E2%80%9369%20years.%203.0%25%20for%20those%20aged%2070%E2%80%9374%20years
  10. Age UK (2021). Understanding Dementia [online] [viewed 29 November 2021]. Available from:
  11. Alzheimer’s Society (2020. Types of dementia [online] [viewed 29 November 2021]. Available from:
  12. Dementia UK (2021). Eating and drinking for a person with dementia [online] [viewed 29 November 2021]. Available from:
  13. Social Care Institute for Excellence (2020). Why nutrition is important for people with dementia [online] [viewed 29 November 2021]. Available from:
  14. British Nutrition Foundation (2019). Eating with dementia. The challenges of nutritional care in dementia [online] [viewed 29 November 2021]. Available from:
  15. Macleod F, Storey L, Rushe T and Mclaughlin K (2020). Towards an increased understanding of reminiscence therapy for people with dementia: A narrative analysis. SAGE Journals [online]. 20(4), p 1375-1407 [viewed 29 November 2021]. Available from:
  16. Aldridge Z, Oliver E, Gardener H and Dening KH (2020). Admiral Nursing – A Model of Specialist Dementia Care in Acute Hospitals. SAGE Open Nursing [online]. 6(January), p 1-11 [viewed 22 November 2021]. Available from:



  1. Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2016 Jun 23; 4(1): 30. doi: 10.1186/s40168-016-0171-4. PMID: 27338587; PMCID: PMC4918027
  2. Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, Chu L, Younger JW, Tato CM, Davis MM. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci U S A. 2017 Aug 22; 114(34): E7150-E7158. doi: 10.1073/pnas.1710519114. Epub 2017 Jul 31. PMID: 28760971; PMCID: PMC5576836
  3. Morris G, Anderson G, Maes M. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways. Mol Neurobiol. 2017 Nov; 54(9): 6806-6819. doi: 10.1007/s12035-016-0170-2. Epub 2016 Oct 20. PMID: 27766535
  4. Behan WM, More IA, Behan PO. Mitochondrial abnormalities in the post-viral fatigue syndrome. Acta Neuropathol. 1991;83(1):61-5. doi: 10.1007/BF00294431. PMID: 1792865
  5. Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. 2020 Sep 24; 18(1): 365. doi: 10.1186/s12967-020-02533-3. PMID: 32972442; PMCID: PMC7512220
  6. Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014 Mar; 29(1): 19-36. doi: 10.1007/s11011-013-9435-x. Epub 2013 Sep 10. PMID: 24557875
  7. Cara Tomas and Joanna L Elson (2019). The role of mitochondria in ME/CFS: a perspective, Fatigue: Biomedicine, Health & Behaviour, 7:1, 52-58, DOI: 10.1080/21641846.2019.1580855
  8. Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014 Mar;29(1):19-36. doi: 10.1007/s11011-013-9435-x. Epub 2013 Sep 10. PMID: 24557875.
  9. Nicolson GL. Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements. Integr Med (Encinitas). 2014 Aug; 13(4): 35-43. PMID: 26770107; PMCID: PMC4566449
  10. Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci USA. 2021 Aug 24; 118(34):e2024358118. doi: 10.1073/pnas.2024358118. PMID: 34400495; PMCID: PMC8403932
  11. Maksoud R, Balinas C, Holden S, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2021 Feb 17; 19(1): 81. doi: 10.1186/s12967-021-02742-4. PMID: 33596913; PMCID: PMC7890871
  12. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett. 2009; 30(4): 470-6. PMID: 20010505
  13. Jing L, He MT, Chang Y, Mehta SL, He QP, Zhang JZ, Li PA. Coenzyme Q10 protects astrocytes from ROS-induced damage through inhibition of mitochondria-mediated cell death pathway. Int J Biol Sci. 2015 Jan 1; 11(1): 59-66. doi: 10.7150/ijbs.10174. PMID: 25552930; PMCID: PMC4278255
  14. Cordero MD, Alcocer-Gómez E, Culic O, Carrión AM, de Miguel M, Díaz-Parrado E, Pérez-Villegas EM, Bullón P, Battino M, Sánchez-Alcazar JA. NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal. 2014 Mar 10; 20(8): 1169-80. doi: 10.1089/ars.2013.5198. Epub 2013 Sep 19. PMID: 23886272; PMCID: PMC3934515
  15. Castro-Marrero J, Cordero MD, Segundo MJ, Sáez-Francàs N, Calvo N, Román-Malo L, Aliste L, Fernández de Sevilla T, Alegre J. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. 2015 Mar 10; 22(8): 679-85. doi: 10.1089/ars.2014.6181. Epub 2014 Dec 18. PMID: 25386668; PMCID: PMC4346380
  16. Pendergrast T, Brown A, Sunnquist M, Jantke R, Newton JL, Strand EB, Jason LA. Housebound versus non-housebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016 Dec; 12(4): 292-307. doi: 10.1177/1742395316644770. Epub 2016 Apr 28. PMID: 27127189; PMCID: PMC5464362
  17. Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, Chope G, Hyppönen E, Berry J, Vieth R, Lanham-New S. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012 Jun; 95(6): 1357-64. doi: 10.3945/ajcn.111.031070. Epub 2012 May 2. PMID: 22552031; PMCID: PMC3349454


OBESITY SURGERY by Hazel Windsor-Aubrey

  1. National Institute for Health and Care Excellence (NICE) (2006). Obesity: Guidance of the prevention, identification, assessment and management of overweight and obesity in adults and children. London: NICE. Last accessed 02/11/21
  2. Mechanick JI, Kushner RF, Sugerman HJ et al. American Association of Clinical Endocrinologists, The Obesity Society and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice. Endocrinology Practice. 2008; 14: 1-83
  3. National Bariatric Surgery Registry (NBSR) (2020). The United Kingdom National Bariatric Surgery Registry, Third Registry Report 2020. Available: Last accessed 02/11/21
  4. Karlsson J, Taft C, Rydén A, Sjöström L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. International Journal of Obesity, 2007, 31(8): 1248-61
  5. Tavares A, Viveiros F, Cidade C, Maciel J. Bariatric surgery: epidemic of the XXI century Acta Méd Portuguesa, 24 (2011), p 111-116
  6. Gil R Faria. A brief history of bariatric surgery. Porto Biomedical Journal, 2(3), 2017, 90-92
  7. Schweiger C, Weiss R, Berry E, Keidar A. Nutritional deficiencies in bariatric surgery candidates. Obesity Surgery, 2010; 20: 193-7
  8. York LW, Puthalapattu S, Wu GY. Nonalcoholic fatty liver disease and low-carbohydrate diets. Annual Review of Nutrition 2009; 29: 365-79
  9. Gill HK, Wu GY. Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low-carbohydrate diets the answer? World Journal of Gastroenterology, 2006; 12: 345-53
  10. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S. A randomised trial of a low-carbohydrate diet for obesity. New England Journal of Medicine, 2003; 348: 2082-90
  11. Van Wissen J, Bakker N, Doodeman HJ, Jansma EP, Bonjer HJ, Houdijk AP. Preoperative methods to reduce liver volume in bariatric surgery: a systematic review. Obesity Surgery, 2016; 26: 251-6
  12. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S et al. Clinical practice guidelines for the perioperative nutritional, metabolic and nonsurgical support of the bariatric surgery patient. 2013 update: Obesity, 2013; 21(Suppl 1): S1-27
  13. Ministry of Health. Bariatric surgery registry of the Ministry of Health [Internet] [cited 2016 Sep 4]
  14. Borisenko O, Colpan Z, Dillemans B, Finch-Jensen P. Clinical indications, utilisation and funding of bariatric surgery in Europe (2014). Obesity Surgery, 25, 8
  15. NHS digital. Statistics on obesity, physical activity and diet, England 2020. Statistics on obesity, physical activity and diet



  1. Whiteley VJ, Martin-McGill KJ, Carroll JH, Taylor H, Schoeler NE. Ketogenic Dietitians Research Network (KDRN). Nice to know: impact of NICE guidelines on ketogenic diet services nationwide. J Hum Nutr Diet. 2020 Feb; 33(1): 98-105. doi: 10.1111/jhn.12697. Epub 2019 Aug 20. PMID: 31429508
  2. Martin-McGill KJ, Lambert B, Whiteley VJ, Wood S, Neal EG, Simpson ZR, Schoeler NE. Ketogenic Dietitians Research Network (KDRN). Understanding the core principles of a 'modified ketogenic diet': a UK and Ireland perspective. J Hum Nutr Diet. 2019 Jun; 32(3): 385-390. doi: 10.1111/jhn.12637
  3. Schoeler NE, Simpson Z, Whiteley VJ, Nguyen P, Meskell R, Lightfoot K, Martin-McGill KJ, Olpin S, Ivison F and Ketogenic Dietitians Research Network (KDRN) (2019). Biochemical assessment of patients following ketogenic diets for epilepsy: Current practice in the UK and Ireland. Epilepsia open, 5(1), 73-79.
  4. Lambert B, Lightfoot K, Meskell R, Whiteley VJ, Martin-McGill KJ, Schoeler NE. Keto-on-the-Clock: A Survey of Dietetic Care Contact Time Taken to Provide Ketogenic Diets for Drug-Resistant Epilepsy in the UK. Nutrients 2021, 13, 2484.
  5. Wilder RM. The effects of ketonuria on the course of epilepsy. Mayo Clin Bull, 1921, 2 307-308
  6. Huttenlocher PR, Wilbourn AJ, Signore JM Medium chain triglycerides as a therapy for intractable childhood epilepsy. Neurology, 1971, 21 1097-1103
  7. Vining EPG, Freeman JM, Ballaban-Gil K et al. A Multicentre Study of the Efficacy of the Ketogenic Diet. Arch Neurol. 1998; 55(11): 1433-1437. doi:10.1001/archneur.55.11.1433
  8. Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006 Feb; 47(2): 421-4. doi: 10.1111/j.1528-1167.2006.00438.x. PMID: 16499770
  9. Pfeifer HH, Thiele EA. Low glycaemic index treatment: a liberalised ketogenic diet for treatment of intractable epilepsy. Neurology, 2005, 65 1810-1812
  10. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008 Jun;7(6): 500-6. doi: 10.1016/S1474-4422(08)70092-9
  11. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH. A randomised trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009 May; 50(5): 1109-17. doi: 10.1111/j.1528-1167.2008.01870.x
  12. Kossoff EH (2008). International consensus statement on clinical implementation of the ketogenic diet: agreement, flexibility, and controversy. Epilepsia, 49, 11-13
  13. Levy RG, Cooper PP. Ketogenic diet for epilepsy. Cochrane Database of Systematic Reviews 2003, Issue 3. Art No: CD001903. DOI: 10.1002/14651858.CD001903
  14. Levy RG, Cooper PN, Giri P, Weston J. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Systematic Reviews 2012, Issue 3. Art No: CD001903. DOI: 10.1002/14651858.CD001903
  15. Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Systematic Reviews 2016, Issue 2. Art No: CD001903. DOI: 10.1002/14651858.CD001903
  16. Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug‐resistant epilepsy. Cochrane Database of Systematic Reviews 2020, Issue 6. Art No: CD001903. DOI: 10.1002/14651858.CD001903
  17. National Institute for Health and Care Excellence Clinical guideline [CG137]. Epilepsies: diagnosis and management. January 2012 (updated April 2018)
  18. Scottish Intercollegiate Guidelines Network (SIGN). Epilepsies in children and young people: Investigative procedures and management. 2021
  19. van der Louw E, van den Hurk D, Neal E, Leiendecker B, Fitzsimmon G, Dority L, Thompson L, Marchió M, Dudzińska M, Dressler A, Klepper J, Auvin S, Cross JH. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol. 2016 Nov; 20(6): 798-809. doi: 10.1016/j.ejpn.2016.07.009
  20. Cervenka MC, Wood S, Bagary M, Balabanov A, Bercovici E, Brown MG, Devinsky O, Di Lorenzo C, Doherty CP, Felton E, Healy LA, Klein P, Kverneland M, Lambrechts D, Langer J, Nathan J, Munn J, Nguyen P, Phillips M, Roehl K, Tanner A, Williams C, Zupec-Kania B. International Recommendations for the Management of Adults Treated with Ketogenic Diet Therapies. Neurol Clin Pract. 2021 Oct;11(5): 385-397. doi: 10.1212/CPJ.0000000000001007
  21. van der Louw E, Aldaz V, Harvey J, Roan M, van den Hurk D, Cross JH, Auvin S; Review Group. Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide. Dev Med Child Neurol. 2020 Jan; 62(1): 48-56. doi: 10.1111/dmcn.14306
  22. Zare M, Okhovat AA, Esmaillzadeh A, Mehvari J, Najafi MR, Saadatnia M. Modified Atkins diet in adult with refractory epilepsy: A controlled randomised clinical trial. Iran J Neurol. 2017; 16(2): 72-77
  23. Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC; Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 May 21; 3(2): 175-192. doi: 10.1002/epi4.12225